Historical perspective fifty years of particles: a personal retrospect

Revisiting the atmospheric particles: Connecting lines and changing paradigms

Historically, the atmospheric particles constitute the most primitive and recent class of air pollutants. The science of atmospheric particles erupted more than a century ago covering more than four decades of size, with past few years experiencing major advancements on both theoretic and data-based observational grounds. More recently, the plausible recognition between particulate matter (PM) and the diffusion of the COVID-19 pandemic has led to the accretion of interest in particle science. With motivation from diverse particle research interests, this paper is an 'old engineer's survey' beginning with the evolution of atmospheric particles and identifies along the way many of the global instances signaling the 'size concept' of PM. A theme that runs through the narrative is a 'previously known' generational evolution of particle science to the 'newly procured' portfolio of knowledge, with important gains on the application of unmet concepts and future approaches to PM exposure and epidemiological research.

Particle toxicology and health - where are we?

BACKGROUND

Particles and fibres affect human health as a function of their properties such as chemical composition, size and shape but also depending on complex interactions in an organism that occur at various levels between particle uptake and target organ responses. While particulate pollution is one of the leading contributors to the global burden of disease, particles are also increasingly used for medical purposes. Over the past decades we have gained considerable experience in how particle properties and particle-bio interactions are linked to human health. This insight is useful for improved risk management in the case of unwanted health effects but also for developing novel medical therapies. The concepts that help us better understand particles' and fibres' risks include the fate of particles in the body; exposure, dosimetry and dose-metrics and the 5 Bs: bioavailability, biopersistence, bioprocessing, biomodification and bioclearance of (nano)particles. This includes the role of the biomolecule corona, immunity and systemic responses, non-specific effects in the lungs and other body parts, particle effects and the developing body, and the link from the natural environment to human health. The importance of these different concepts for the human health risk depends not only on the properties of the particles and fibres, but is also strongly influenced by production, use and disposal scenarios.

CONCLUSIONS

Lessons learned from the past can prove helpful for the future of the field, notably for understanding novel particles and fibres and for defining appropriate risk management and governance approaches.